| 1 | | | | | | | | 15 | 7.89% |
| 2 | neurodevelopmental syndromes and movement | | | | | | | 2 | 1.05% |
| 3 | home committee program registration | | | | | | | 1 | 0.53% |
| 4 | is to pursue the | | | | | | | 1 | 0.53% |
| 5 | scientific collaboration in the | | | | | | | 1 | 0.53% |
| 6 | disorders we intend for | | | | | | | 1 | 0.53% |
| 7 | movement disorders we intend | | | | | | | 1 | 0.53% |
| 8 | and movement disorders we | | | | | | | 1 | 0.53% |
| 9 | syndromes and movement disorders | | | | | | | 1 | 0.53% |
| 10 | committee program registration to | | | | | | | 1 | 0.53% |
| 11 | among professionals interested in | | | | | | | 1 | 0.53% |
| 12 | activities among professionals interested | | | | | | | 1 | 0.53% |
| 13 | collaborative activities among professionals | | | | | | | 1 | 0.53% |
| 14 | enjoyable mediterranean atmosphere | | | | | | | 1 | 0.53% |
| 15 | mediterranean atmosphere | | | | | | | 1 | 0.53% |
| 16 | atmosphere | | | | | | | 1 | 0.53% |
| 17 | our aim is to | | | | | | | 1 | 0.53% |
| 18 | aim is to pursue | | | | | | | 1 | 0.53% |
| 19 | the best international qualified experts | | | | | | | 1 | 0.53% |
| 20 | lifespan our aim is | | | | | | | 1 | 0.53% |
| 21 | the lifespan our aim | | | | | | | 1 | 0.53% |
| 22 | across the lifespan our | | | | | | | 1 | 0.53% |
| 23 | comorbidities across the lifespan | | | | | | | 1 | 0.53% |
| 24 | and comorbidities across the | | | | | | | 1 | 0.53% |
| 25 | this | | | | | | | 1 | 0.53% |
| 26 | this year | | | | | | | 1 | 0.53% |
| 27 | epileptic encephalopathies movement disorders | | | | | | | 1 | 0.53% |
| 28 | and epileptic encephalopathies movement | | | | | | | 1 | 0.53% |
| 29 | neurodevelopmental and epileptic encephalopathies | | | | | | | 1 | 0.53% |
| 30 | this year we | | | | | | | 1 | 0.53% |
| 31 | this year we will | | | | | | | 1 | 0.53% |
| 32 | will be able to | | | | | | | 1 | 0.53% |
| 33 | strengthen scientific collaboration in | | | | | | | 1 | 0.53% |
| 34 | international qualified experts | | | | | | | 1 | 0.53% |
| 35 | neurodegeneration behavioral abnormalities in | | | | | | | 1 | 0.53% |
| 36 | and hope that this | | | | | | | 1 | 0.53% |
| 37 | where you will be | | | | | | | 1 | 0.53% |
| 38 | you where you will | | | | | | | 1 | 0.53% |
| 39 | of you where you | | | | | | | 1 | 0.53% |
| 40 | all of you where | | | | | | | 1 | 0.53% |